首页> 外国专利> USE OF MELATONIN FOR PREPARING MEDICAMENTS FOR TREATING CIRCADIAN RHYTHM PHASE DISORDERS

USE OF MELATONIN FOR PREPARING MEDICAMENTS FOR TREATING CIRCADIAN RHYTHM PHASE DISORDERS

机译:褪黑素在制备治疗西尔迪安律失常的药物中的用途

摘要

A method for treating circadian rhythm disorders is described. The method involves the administration of melatonin, melatonin agonists or compounds that stimulate endogenous melatonin production so that the durations of the effective plasma concentrations of melatonin, melatonin agonists or compounds that stimulate endogenous melatonin production overlap with onset or offset of pre-treatment endogenous melatonin production, to provide a circadian-rhythm phase advance or phase delay, respectively. The methods of the invention also provide for concentration and/or duration of the effective plasma concentrations of melatonin, melatonin agonists or compounds that stimulate endogenous melatonin production to be greater in the time interval between about 8 hours before the dim light endogenous melatonin onset (DLMO) to about 4 hours after DLMO than in the time interval from about 4 hours after DLMO to about 8 hours before DLMO to achieve a circadian-rhythm phase advance. The methods of the invention also provide for concentration and/or duration of the effective plasma concentrations of melatonin, melatonin agonists or compounds that stimulate endogenous melatonin production to be greater in the time interval between about 4 hours after DLMO to about 8 hours before DLMO than in the time interval from about 8 hours before DLMO time to about 4 hours after DLMO to achieve a circadian- rhythm phase delay. In addition, the invention provides methods for regulating a human's exposure to light and dark to prevent or enhance, respectively, the human's endogenous production of melatonin. The use of melatonin antagonists, inverse agonists and melatonin inhibitory compounds such as beta-blockers for achieving a circadian-rhythm phase-shifting effect (opposite to that of melatonin administration) are also provided by the invention. The methods of the invention are illustrated by teachings for use of these methods for alleviating a variety of circadian rhythm-related disorders, including jet lag, winter depression, shift work-related desynchronies and sleep phase disorders.
机译:描述了一种治疗昼夜节律障碍的方法。该方法涉及施用褪黑激素,褪黑激素激动剂或刺激内源性褪黑激素产生的化合物,从而使有效血浆浓度的褪黑激素,褪黑激素激动剂或刺激内源性褪黑激素产生的化合物的持续时间与治疗前内源性褪黑激素产生的开始或抵消重叠。分别提供昼夜节律相位提前或相位延迟。本发明的方法还提供了褪黑激素,褪黑激素激动剂或刺激内源性褪黑激素产生的化合物的有效血浆浓度的浓度和/或持续时间,在昏暗的内源性褪黑激素发作(DLMO)之前约8小时的时间间隔内更大。 )至DLMO后约4小时,而不是从DLMO后约4小时到DLMO前约8小时的时间间隔,以达到昼夜节律阶段的进展。本发明的方法还提供了褪黑激素,褪黑激素激动剂或刺激内源性褪黑激素产生的化合物的有效血浆浓度的浓度和/或持续时间,其在DLMO后约4小时至DLMO前约8小时之间大于在从DLMO前约8小时到DLMO后约4小时的时间间隔内,可以达到昼夜节律的相位延迟。另外,本发明提供了调节人类暴露于明暗的方法,以分别预防或增强人类内源性褪黑激素的产生。本发明还提供了褪黑激素拮抗剂,反向激动剂和褪黑激素抑制性化合物例如β-受体阻滞剂用于昼夜节律相移作用(与褪黑激素给药相反)的用途。通过使用这些方法来减轻与昼夜节律有关的各种疾病的教导来说明本发明的方法,这些疾病包括时差,冬季抑郁,轮班相关的失调和睡眠阶段疾病。

著录项

  • 公开/公告号CA2289093C

    专利类型

  • 公开/公告日2010-09-14

    原文格式PDF

  • 申请/专利权人 OREGON HEALTH SCIENCES UNIVERSITY;

    申请/专利号CA19982289093

  • 发明设计人 SACK ROBERT L.;LEWY ALFRED J.;

    申请日1998-04-29

  • 分类号A61K31/40;A61K31/4045;

  • 国家 CA

  • 入库时间 2022-08-21 18:42:54

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号